Form 4: Orchestra BioMed CFO Andrew Taylor Acquires 1,000 Shares

Orchestra BioMed's Chief Financial Officer, Andrew Taylor, purchased 1,000 shares of common stock at a weighted average price of $4.83.

Summary

• Andrew Taylor, the Chief Financial Officer of Orchestra BioMed Holdings, Inc., acquired 1,000 shares of the company's common stock on December 19, 2024.
• The shares were purchased at a weighted average price of $4.83 per share.
• The transactions occurred at prices ranging from $4.81 to $4.89.
• Following this transaction, Mr. Taylor directly owns 344,960 shares of Orchestra BioMed common stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive as it reflects an insider purchase, which can be seen as a sign of confidence, but the transaction is small and routine.

Positives

• The purchase of shares by a company executive can be seen as a positive sign of confidence in the company's future.

Industry Context

Insider trading activity is a common occurrence in publicly traded companies, and this transaction is a routine disclosure of such activity.

Comparison to Industry Standards

• Form 4 filings are standard practice for reporting insider transactions in publicly traded companies.
• The purchase of 1,000 shares is a relatively small transaction compared to the total shares outstanding for Orchestra BioMed.

Stakeholder Impact

• The purchase may have a minor positive impact on shareholder sentiment.

Key Dates

Keywords

Orchestra BioMed, Andrew Taylor, insider trading, share purchase, common stock, CFO, OBIO